FDA outlines regulatory science priorities

FDA identified eight priorities in the Strategic Plan for Regulatory Science the agency released on Wednesday, two days ahead of a Science Board meeting to discuss the plan. The priority areas include preclinical toxicology; personalized medicine; manufacturing; evaluation of emerging technologies; using information sciences to improve health outcomes; food safety; medical countermeasures; and communication with consumers and professionals. ...